Clinical Trial Update: Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cabergoline for lactation inhibition after second-trimester abortion or loss has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lactation Suppression

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Stanford University | Conditions: Lactation Suppressed | Phase 2 | Status: COMPLETED | Results posted: 2023-04-05